DNA methylation-based classification of sinonasal undifferentiated carcinoma.


Journal

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
ISSN: 1530-0285
Titre abrégé: Mod Pathol
Pays: United States
ID NLM: 8806605

Informations de publication

Date de publication:
10 2019
Historique:
received: 21 02 2019
accepted: 15 04 2019
revised: 11 04 2019
pubmed: 13 6 2019
medline: 26 6 2020
entrez: 13 6 2019
Statut: ppublish

Résumé

Sinonasal undifferentiated carcinoma (SNUC) is an aggressive malignancy harboring IDH2 R172 mutations in >80% cases. We explored the potential of genome-wide DNA methylation profiling to elucidate tumor biology and improve the diagnosis of sinonasal undifferentiated carcinoma and its histologic mimics. Forty-two cases, including sinonasal undifferentiated, large cell neuroendocrine, small cell neuroendocrine, and SMARCB1-deficient carcinomas and olfactory neuroblastoma, were profiled by Illumina Infinium Methylation EPIC array interrogating >850,000 CpG sites. The data were analyzed using a custom bioinformatics pipeline. IDH2 mutation status was determined by the targeted exome sequencing (MSK-IMPACT

Identifiants

pubmed: 31186531
doi: 10.1038/s41379-019-0285-x
pii: S0893-3952(22)00999-1
pmc: PMC7391258
mid: NIHMS1611775
doi:

Substances chimiques

SMARCB1 Protein 0
SMARCB1 protein, human 0
Isocitrate Dehydrogenase EC 1.1.1.41

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1447-1459

Subventions

Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States

Références

Bioinformatics. 2014 May 15;30(10):1363-9
pubmed: 24478339
Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Feb;119(2):213-20
pubmed: 25434692
Mod Pathol. 2019 Feb;32(2):205-215
pubmed: 30206411
Am J Surg Pathol. 2014 Sep;38(9):1274-81
pubmed: 24832165
J Clin Pathol. 1995 Sep;48(9):876-8
pubmed: 7490328
Hum Pathol. 1998 Aug;29(8):826-32
pubmed: 9712424
N Engl J Med. 2009 Sep 10;361(11):1058-66
pubmed: 19657110
Oncologist. 2012;17(1):72-9
pubmed: 22180306
Cell. 2016 Feb 25;164(5):1060-1072
pubmed: 26919435
OMICS. 2012 May;16(5):284-7
pubmed: 22455463
JCO Precis Oncol. 2017 Jul;2017:
pubmed: 28890946
Mod Pathol. 2017 May;30(5):650-659
pubmed: 28084339
Adv Anat Pathol. 2005 May;12(3):134-43
pubmed: 15900114
JCO Precis Oncol. 2017;2017:
pubmed: 29354796
Nat Med. 2017 Jun;23(6):703-713
pubmed: 28481359
Am J Surg Pathol. 2011 Jul;35(7):971-80
pubmed: 21677536
Head Neck. 2016 Apr;38 Suppl 1:E2259-66
pubmed: 26041714
Blood. 2012 Feb 23;119(8):1901-3
pubmed: 22215888
Am J Surg Pathol. 1986 Nov;10(11):771-9
pubmed: 2430477
Nature. 2018 Mar 22;555(7697):469-474
pubmed: 29539639
Cancer Cell. 2010 Dec 14;18(6):553-67
pubmed: 21130701
Am J Surg Pathol. 2017 Apr;41(4):458-471
pubmed: 28291122
Hum Pathol. 2019 Jan;83:59-67
pubmed: 30120966
Am J Clin Pathol. 2005 Dec;124 Suppl:S110-21
pubmed: 16468421
J Pathol. 2017 Aug;242(4):400-408
pubmed: 28493366
J Clin Oncol. 2005 Dec 1;23(34):8774-85
pubmed: 16314638
Nature. 2012 Feb 15;483(7390):479-83
pubmed: 22343889
Acta Neuropathol. 2018 Aug;136(2):255-271
pubmed: 29730775
Neurosurg Focus. 2002 May 15;12(5):e3
pubmed: 16119901
Oncologist. 2017 Jul;22(7):834-842
pubmed: 28495808
Am J Surg Pathol. 2016 Apr;40(4):471-8
pubmed: 26735857
N Engl J Med. 2009 Feb 19;360(8):765-73
pubmed: 19228619
Methods Mol Biol. 2018;1741:31-51
pubmed: 29392688
Cancer Cell. 2016 Mar 14;29(3):379-393
pubmed: 26923874
Mol Cancer Res. 2017 Nov;15(11):1551-1557
pubmed: 28775129
Am J Surg Pathol. 2018 May;42(5):665-671
pubmed: 29438167
Am J Surg Pathol. 2014 Sep;38(9):1282-9
pubmed: 25007146
Nature. 2012 Feb 15;483(7390):474-8
pubmed: 22343901
PLoS One. 2018 Jan 11;13(1):e0191244
pubmed: 29324814
Am J Surg Pathol. 2012 Aug;36(8):1216-21
pubmed: 22534723
Int Arch Otorhinolaryngol. 2014 Oct;18(Suppl 2):S149-56
pubmed: 25992139
J Laryngol Otol. 2006 Apr;120(4):289-97
pubmed: 16526967
J Pathol. 2011 Jul;224(3):334-43
pubmed: 21598255
Cell Rep. 2018 Oct 16;25(3):811-821.e5
pubmed: 30332658
J Mol Diagn. 2015 May;17(3):251-64
pubmed: 25801821
Cancer Res. 2016 Dec 15;76(24):7118-7129
pubmed: 27913435

Auteurs

Snjezana Dogan (S)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. dogans@mskcc.org.

Varshini Vasudevaraja (V)

Department of Pathology, NYU Langone Health and School of Medicine, New York, NY, USA.

Bin Xu (B)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Jonathan Serrano (J)

Department of Pathology, NYU Langone Health and School of Medicine, New York, NY, USA.

Ryan N Ptashkin (RN)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Hun Jae Jung (HJ)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Sarah Chiang (S)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Achim A Jungbluth (AA)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Marc A Cohen (MA)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Ian Ganly (I)

Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Michael F Berger (MF)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Amir Momeni Boroujeni (A)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Ronald A Ghossein (RA)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Marc Ladanyi (M)

Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Deborah J Chute (DJ)

Department of Pathology, Cleveland Clinic Foundation, Cleveland, OH, USA.

Matija Snuderl (M)

Department of Pathology, NYU Langone Health and School of Medicine, New York, NY, USA.
Laura and Isaac Perlmutter Cancer Center, NYU Langone Health and School of Medicine, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH